The NeuroBlate® System is a minimally invasive robotically controlled laser thermotherapy that uses MRI-guided laser light to ablate (destroy) unwanted tissue in the brain where the lesion, or abnormal tissue originates.
The NeuroBlate procedure is a minimally invasive procedure. Generally, minimally invasive procedures:
Are well tolerated
Have a short recovery time
Have nominal incision-patients go home with 1-2 stitches
Explore what to expect before, during, and after ablation with the NeuroBlate System.
- Pre-Surgical Evaluation
Prior to having brain surgery, a surgical evaluation is necessary. The specific pre-operative tests depend on the type of surgery but may include:
- Full health assessment
- Evaluation of the brain lesion and the surrounding brain tissue
Your doctor will advise you of any pre-procedure requirements such as potentially stopping medications or avoiding food and drink prior to the procedure.
You will receive anesthesia before the procedure. Your doctor will determine what level of anesthesia is right for you. With the NeuroBlate System, doctors create a small hole in the skull, about the diameter of a pencil. While the patient is in the MRI machine, the doctor guides a small laser device (probe) through the hole into the brain lesion. The probe delivers laser light energy (laser ablation) that heats and destroys the affected tissue.
- Because the NeuroBlate System is MRI-guided, the neurosurgeon is able to visualize the specific area of the brain to be ablated. The precise nature of the procedure helps to lessen the likelihood of harm to nearby healthy brain tissue.1,2,3,4
- Generally minimally invasive procedures are well tolerated and have a short recovery time.
- You will have 1-2 stitches to close the incision.
- You may also have scratches on your head from the device that helps keep your head in position.
- You will schedule follow-up appointment(s) with your doctor as instructed.
Indications & Risks
The NeuroBlate System is a surgical tool used in brain surgery to heat and destroy targeted tissue. Patients must be able to undergo MRI exposure. All brain surgeries carry risk. Discuss with your physician the potential benefits and risk, e.g., device malfunction, bleeding, edema and unintended major brain tissue damage and permanent neurological deficits.
- Wilson TA, Karajannis MA, and Harter DH. Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014 May 8;5:64.
- Mohammadi, AM and Schroeder, JL. Laser interstitial thermal therapy in treatment of brain tumors – the NeuroBlate® System. Expert Review of Medical Devices 2014 11:2, 109-119.
- Sloan AE, Ahluwalia MS, Valerio-Pascua J, et al. Results of the NeuroBlate® System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg. 2013 Jun;118(6):1202-19.
- Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer- controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011 Dec;43(10):943-50.